Search Results for “EC” – Page 564 – media

Japan Just Approved a New Drug That Can Kill the Flu Virus In Just One Day

As the worst flu season in a decade rages on, a potentially groundbreaking new drug that can kill the flu virus in just one day has won regulatory approval—in Japan.
- Source: Fortune
- 697
- February 28, 2018
flu New Approvals virus
Bay Area’s Rani Therapeutics Lands $53M as Company Moves to Clinical Trials

Rani Therapeutics scored $53 million in financing to take its oral pill designed to replace injectable drug delivery for chronic disease treatment into clinical trials.
- Source: Biospace
- 466
- February 28, 2018
chronic diseases Company Insight oral pill
AZ/MSD’s Lynparza wins new CHMP nod

AstraZeneca and MSD’s Lynparza is a step closer to being cleared in Europe as maintenance therapy for some patients with ovarian cancer.
- Source: pharmatimes
- 542
- February 28, 2018
AstraZeneca Chemotherapy MSD New Approvals ovarian cancer
Implanted continuous glucose sensor proven safe

Senseonics Holdings Inc has announced that people with diabetes using the Eversense® brand Continuous Glucose Monitoring Systems, in EMEA markets now have the option to invite others to remotely view their real-time glucose readings and alerts from anywhere.
- Source: globalbiotechinsights
- 710
- February 28, 2018
diabetes medical device mHealth New Approvals
Samsung’s Galaxy S9 to include blood pressure monitor, research app

Samsung’s latest phones, the Galaxy S9 and S9+, will incorporate a new digital health app that will track users' blood pressure and stress level while helping researchers collect data. Seoul-based Samsung Electronics teamed up with the University of California San Fransisco to develop the research app, called My BP Lab.
- Source: mobihealthnews
- 663
- February 28, 2018
Company Insight digital health medical device mHealth
Cognoa’s AI platform for autism diagnosis gets first FDA stamp

Cognoa has gained regulatory recognition for its machine learning software as a class II diagnostic medical device for autism — meaning the digital health startup is now positioned to submit an application for full FDA clearance.
- Source: Techcrunch
- 593
- February 27, 2018
AI autism FDA New Approvals
Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics

Orthotaxy’s Technology Will Be Leveraged to Develop Cost-Effective, Time-Efficient, User-Friendly Offering in a Broad Range of Orthopaedics Procedures.
- Source: Jnj
- 517
- February 27, 2018
Market Views Orthopaedics
XOC PHARMACEUTICALS ANNOUNCES $30 MILLION SERIES A FINANCING LED BY NEA

Company to move forward with novel therapies for migraine and Parkinson’s disease
- Source: xocpharma
- 535
- February 27, 2018
CNS migraine Parkinson’s disease Series
UK’s NHS Aims to Build a Library of Reliable Mobile Health Apps.

The UK's National Health Service is putting out the call for more mobile health apps for its NHS Apps Library, and has chosen an agency to certify those apps. The library now features 46 mHealth apps - only one of which has passed muster.
- Source: mHealth Intelligence
- 645
- February 27, 2018
Company Insight digital health mHealth
Gilead links with Sangamo in gene therapy alliance

Gilead’s Kite is linking with Sangamo Therapeutics in a collaboration that aims to develop next-generation engineered cell therapies for the treatment of cancer.
- Source: drugdu
- 539
- February 26, 2018
cancer engineered cell therapies Gilead Market Views

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.